Ziprasidone and the Corrected QT Interval

Second-Generation (Atypical) Antipsychotics and Metabolic Effects

2005 • 1,335 citations

Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states.

2006 • 1,267 citations

Schizophrenia and increased risks of cardiovascular disease

2005 • 1,055 citations

Excess mortality of schizophrenia

1997 • 880 citations

Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden Death

2002 • 422 citations

Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes

2007 • 365 citations

A Randomized Evaluation of the Effects of Six Antipsychotic Agents on QTc, In the Absence and Presence of Metabolic Inhibition

2004 • 354 citations

Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group

1997 • 311 citations

Bipolar disorder and metabolic syndrome: An international perspective

2010 • 201 citations

The Level of Cardiovascular Risk Factors in Bipolar Disorder Equals That of Schizophrenia

2007 • 175 citations

Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second‐generation antipsychotics

2008 • 152 citations

Comparative Mortality Associated With Ziprasidone and Olanzapine in Real-World Use Among 18,154 Patients With Schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)

2010 • 119 citations

Drug-induced spatial dispersion of repolarization.

2008 • 87 citations

Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.

1998 • 77 citations

Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: A randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder

2010 • 43 citations

Effects of Oral Ziprasidone and Oral Haloperidol on QTc Interval in Patients with Schizophrenia or Schizoaffective Disorder

2010 • 40 citations

Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report

2010 • 34 citations

Covariate Analysis of QTc and T-Wave Morphology: New Possibilities in the Evaluation of Drugs That Affect Cardiac Repolarization

2010 • 29 citations

The Sertindole Safety Survey: A retrospective analysis under a named patient use programme in Europe

2008 • 19 citations

Sertindole in clinical practice

1998 • 1 citations